XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 8,931,054 $ 1,718,645
Prepaid expenses and other current assets 53,405 885
Current assets held for sale 5,481,187 5,574,748
Total current assets 14,465,646 7,294,278
Non-current assets held for sale 3,139,720 3,341,032
Total assets 17,605,366 10,635,310
Current liabilities:    
Accounts payable 756,703 764,333
Accrued expenses 199,703 99,641
Accrued Series A Convertible Preferred payments payable 1,846,142 1,909,496
Warrant Liability 8,292,000  
Current liabilities held for sale 16,037,436 15,254,195
Total current liabilities 27,131,984 18,027,665
Non-current liabilities held for sale 57,590 75,223
Total liabilities 27,189,574 18,102,888
Commitments and contingencies (see note 9)
Stockholders' Equity/(Deficit):    
Common stock (par value $0.0001 per share, 7,000,000,000 and 7,000,000,000 shares authorized at March 31, 2025, and December 31, 2024, respectively; 2,052,762 and 421,124 shares issued and outstanding as of March 31, 2025, and December 31, 2024, respectively) 205 42
Additional paid-in capital 105,883,980 105,740,751
Accumulated deficit (115,468,393) (113,208,371)
Total Stockholders' Deficit (9,584,208) (7,467,578)
Total Liabilities and Stockholders' Deficit $ 17,605,366 $ 10,635,310